UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients

European journal of internal medicine, 2019-09, Vol.67, p.47-58

2019

Volltextzugriff (PDF)

Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy

Journal of hepatology, 2019-07, Vol.71 (1), p.45-51

2019

Volltextzugriff (PDF)

No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients

Scientific reports, 2024-03, Vol.14 (1), p.7534-7534, Article 7534

2024

Volltextzugriff (PDF)

Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals

PloS one, 2019-06, Vol.14 (6), p.e0217052-e0217052

2019

Volltextzugriff (PDF)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy

Scientific reports, 2022-03, Vol.12 (1), p.3828-3828, Article 3828

2022

Volltextzugriff (PDF)

Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV‐infected people on opioid agonist therapy

Journal of viral hepatitis, 2021-06, Vol.28 (6), p.878-886

2021

Volltextzugriff (PDF)

Similar recovery of liver function after response to all‐oral HCV therapy in patients with cirrhosis with and without HIV coinfection

Journal of viral hepatitis, 2019-01, Vol.26 (1), p.16-24

2019

Volltextzugriff (PDF)

Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks

The Journal of infection, 2019-07, Vol.79 (1), p.30-35

2019

Volltextzugriff (PDF)

STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection

Journal of hepatology, 2015-06, Vol.62 (6), p.1246-1255

2015

Volltextzugriff (PDF)

Early emergence of opportunistic infections after starting direct‐acting antiviral drugs in HIV/HCV‐coinfected patients

Journal of viral hepatitis, 2019-01, Vol.26 (1), p.48-54

2019

Volltextzugriff (PDF)

A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure

Diagnostics (Basel), 2021-08, Vol.11 (8), p.1501

2021

Volltextzugriff (PDF)

Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach

Journal of the International Association of Providers of AIDS Care, 2021-01, Vol.20, p.232595822110247-23259582211024771

2021

Volltextzugriff (PDF)

Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy

Revista española de enfermedades digestivas, 2015-04, Vol.107 (4), p.251-251

2015

Volltextzugriff (PDF)

Elite controller cured of hepatitis C virus after 14 weeks of telaprevir-based triple therapy

Revista chilena de infectología, 2015-08, Vol.32 (4), p.486

2015

Volltextzugriff (PDF)

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease

PloS one, 2019-09, Vol.14 (9), p.e0221567

2019

Volltextzugriff (PDF)

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

Gastroenterología y Hepatología (English Edition), 2023-10, Vol.46 (8), p.594-602

2023

Volltextzugriff (PDF)

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis ( GEHEP ) of the Spanish Society of Infectious Diseases and Clinical Microbiology ( SEIMC )

Enfermedades infecciosas y microbiologia clinica (English ed.), 2020-01, Vol.38 (1), p.28-32

2020

Volltextzugriff (PDF)

Meningitis por Cryptococcus gattii : descripción de un caso autóctono en España

Enfermedades infecciosas y microbiología clínica, 2008-07, Vol.26 (6), p.395-396

2008

Volltextzugriff (PDF)

Ten steps to eliminating hepatitis C in hospitals

Nature reviews. Gastroenterology & hepatology, 2022-08, Vol.19 (8), p.481-483

2022

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(58)
Humans
(42)
Infectious Diseases
(35)
Male
(31)
Female
(27)
Hiv
(24)
Middle Aged
(21)
Hepatitis C
(19)
Adult
(18)
Antiviral Agents - Therapeutic Use
(18)
Human Immunodeficiency Virus
(18)
Virology
(17)
Microbiology
(16)
Hepatitis C, Chronic - Drug Therapy
(15)
Immunology
(14)
Treatment Outcome
(13)
Gastroenterology & Hepatology
(12)
Hiv Infections - Drug Therapy
(12)
Direct-Acting Antivirals
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy

Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients

Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders

Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV‐infected people on opioid agonist therapy

Similar recovery of liver function after response to all‐oral HCV therapy in patients with cirrhosis with and without HIV coinfection

Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection

Early emergence of opportunistic infections after starting direct‐acting antiviral drugs in HIV/HCV‐coinfected patients

A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure

Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach

Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy

Elite controller cured of hepatitis C virus after 14 weeks of telaprevir-based triple therapy

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis ( GEHEP ) of the Spanish Society of Infectious Diseases and Clinical Microbiology ( SEIMC )

Meningitis por Cryptococcus gattii : descripción de un caso autóctono en España

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials

Ten steps to eliminating hepatitis C in hospitals

No impact of HIV coinfection on the mortality in patients with hepatitis C virus infection after sustained virological response

Suchergebnisse filtern